Peri-procedural aggressive hydration is associated with significantly decreased rates of post-ERCP pancreatitis (PEP) and appears to be a safe and effective strategy for PEP prevention.
A new international, multicenter study has found that incretin-based drugs, used to treat type 2 diabetes, are not associated with an increased risk of pancreatic cancer.
Risks for pancreatitis, pancreatic cancer higher in Korean patients with newly diagnosed T2DM
The Food and Drug Administration (FDA) has granted accelerated approval to Rozlytrek (entrectinib; Genentech)
Chronic pancreatitis stems from a variety of pathogenic entities that result in chronic inflammation, fibrosis, and irreversible damage to the pancreas.
Most patients diagnosed with incidental pancreatic cysts receive no follow-up care despite multiple published guidelines recommending surveillance. However, a predictor of patients who receive surveillance shows they often follow the recommendation of radiology reports.
The U.S. Preventive Services Task Force (USPSTF) recommends against screening for pancreatic adenocarcinoma as the potential benefits do not outweigh the potential harms.
In an analysis of pancreatic tissue and cyst fluid samples, researchers identified and validated DNA methylation makers that can detect advanced neoplasia.